Preveceutical Medical Inc C.PREV

Alternate Symbol(s): PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).

CSE:PREV - Post by User

Preveceutical Medical Inc > C’mon man... very questionable!

<< Previous

Bullboard Posts

Next >>

Comment by GWA1337on Jun 22, 2020 12:53pm

210 Views

Post# 31177110

RE:C’mon man... very questionable!

Not really. SIF funding is applied for COVID research from GOC which prev applied for. Now making it public news is the first step on pushing towards the potential of getting granted for this research

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”